Select a medication above to begin.
Claritin RediTabs 12 Hour
loratadine
Uses .
- [ loratadine ]
- antihistamine for relieving allergic rhinitis, sneezing, itchy/watery eyes, itchy nose/throat; treating chronic idiopathic urticaria
Dosing .
allergy sx
- [ 6 yo and older ]
- Dose: 1 tab PO q12h prn; Max: 2 tabs/24h
chronic idiopathic urticaria (off-label)
- [ 6 yo and older ]
- Dose: 1 tab PO q12h; Info: some pts may benefit from higher doses, weigh risk/benefit
renal dosing
- [ adjust dose amount ]
- CrCl <30: max 2 tabs/48h
- HD: max 2 tabs/48h; no supplement after dialysis; PD: max 2 tabs/48h; no supplement
hepatic dosing
- [ adjust dose amount ]
- hepatic failure: max 2 tabs/48h
Formulations .
orally disintegrating tablet
- [active ingredients per tab]
- loratadine 5 mg
- [flavors/selected other ingredients]
- mint flavor contains no alcohol, no dye, no phenylalanine, no saccharin, no sucralose, no sugar
Contraindications / Cautions .
- hypersensitivity to drug or ingredient
- caution: hepatic failure
- caution: CrCl <30
- caution: PKU (phenylalanine-containing form)
Drug Interactions .
Overview
loratadine
antihistamine, 2nd generation
- None
No significant interactions known or found for this OTC. Caution always advised with multiple medications.
Adverse Reactions .
Serious Reactions
- bronchospasm
- hepatotoxicity
- anaphylaxis
- anaphylactoid rxn
- syncope
- seizures
- thrombocytopenia
Common Reactions
- drowsiness
- fatigue
- abdominal pain
- headache
- dry mucous membranes
- diarrhea
- pharyngitis
- CNS stimulation, paradoxical
Pregnancy/Lactation .
Pregnancy
Clinical Summary
may use during pregnancy; risk of fetal harm not expected based on limited human data
Lactation
Clinical Summary
may use short-term while breastfeeding, otherwise weigh risk/benefit; no known risk of infant harm based on limited human data and drug properties; inadequate human data available, though theoretical risk of decr. milk production based on decr. prolactin levels
Pharmacology .
Metabolism: liver; CYP450: 2D6,3A4 substrate; Info: active metabolite
Excretion: urine 40%, feces 40%; Half-life: 8.4h (loratadine), 28h (metabolite)
Subclass: Antihistamines, 2nd generation ; Pruritus/Urticaria, Systemic Nonsteroidal Agents
Mechanism of Action: selectively antagonizes peripheral histamine H1 receptors
Alternatives .
Search for Alternative Products by:
- Other OTCs w/ Same Active Ingredient(s)
- Alavert: orally disintegrating tablet
- Children's Claritin: chewable tablet; oral solution
- Claritin: oral tablet/capsule; chewable tablet
- Claritin RediTabs 24 Hour: orally disintegrating tablet
- Related Subclasses
- Anticholinergics, Intranasal
- Antihistamine/Corticosteroid Combos, Intranasal
- Antihistamine/Decongestant Combos
- Antihistamines, 1st generation
- Antihistamines, Intranasal
- Antihistamines, Ophthalmic
- Corticosteroids, Intranasal
- Corticosteroids, Topical 7: Lowest Potency
- Mast Cell Stabilizers, Intranasal
- Mast Cell Stabilizers, Ophthalmic
- Zinc, Homeopathic
- Atopic Dermatitis, Systemic Nonsteroidal Agents
- Pruritus/Urticaria, Topical Nonsteroidal Agents
Pill Pictures
Join Now to View Pill Pictures!
Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.
Current Members: Sign In.